Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04569227
Status:
UNKNOWN
Last Update Posted:
2021-06-10
First Post:
2020-09-28
Brief Title:
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
Sponsor:
Enzychem Lifesciences Corporation
Organization:
Enzychem Lifesciences Corporation
Study Overview
Official Title:
Phase 2 Multi-center Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of EC-18 in Preventing the Progression of COVID-19 Infection to Severe Pneumonia or ARDS
Status:
UNKNOWN
Status Verified Date:
2021-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A trial of EC-18 in patients with mildmoderate pneumonia due to COVID-19
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None